Antibiotic therapy effects on lipidFoxidizing Chlamydia Pneumoniae antibodies in coronary heart disease patients

Antibiotic therapy effects on lipidFoxidizing Chlamydia Pneumoniae antibodies in coronary heart disease patients

.

Bibliographic Details
Main Authors:	N. E. Chalyk, P. Ya. Dovgalevsky, V. A. Klochkov, O. M. Anisimova, I. Petyaev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2006-10-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1946

Similar Items

Whey Protein Lycosome Formulation Improves Vascular Functions and Plasma Lipids with Reduction of Markers of Inflammation and Oxidative Stress in Prehypertension
by: Ivan M. Petyaev, et al.
Published: (2012-01-01)

ISOLATION OF CHLAMYDIA PNEUMONIAE FROM SERUM SAMPLES OF THE PATIENTS WITH ACUTE CORONARY SYNDROME
by: Ivan M Petyaev, Nayilia A Zigangirova, Alexey M Petyaev, Ulia P Pashko, Lubov V Didenko, Elena U Morgunova, Yuriy K Bashmakov
Published: (2010-01-01)

CHLAMYDIA PNEUMONIAE AS A FACTOR OF CORONARY HEART DISEASE DESTABILIZATION
by: Z. G. Gadjiyeva, et al.
Published: (2003-08-01)

EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA
by: P. Ya. Dovgalevsky, et al.
Published: (2016-01-01)

Clinical study of chlamydia pneumoniae infection in patients with coronary heart disease
by: Lei Xue, et al.
Published: (2019-05-01)

Chlamydia pneumoniae, monocyte activation and antimicrobial therapy in coronary heart disease
by: Gupta, Sandeep
Published: (1999)

Iron and the Role of Chlamydia pneumoniae in Heart Disease
by: Jerome L. Sullivan, et al.
Published: (1999-10-01)

Clinical diagnostics role of serum Chlamydia pneumoniae antibodies and acute phase proteins in acute coronary syndrome
by: A. M. Pishchukhina, et al.
Published: (2007-08-01)

CHLAMYDIA PNEUMONIAE – THE PREVALENCE OF ANTIBODIES IN HEALTHY POPULATION AND IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
by: Darja Keše, et al.
Published: (2001-06-01)

Serological investigation of Chlamydia pneumonia in Patients with Coronary Artery Disease
by: Z Shahandeh, et al.
Published: (2009-04-01)

Chlamydia Pneumoniae in the Atherosclerotic Plaques of Coronary Artery Disease Patients
by: Morteza Izadi, et al.
Published: (2013-12-01)

"RELATION OF CHLAMYDIA PNEUMONIAE INFECTION TO DOCUMENTED CORONARY ARTERY DISEASE"
by: M.J. Zibaeenezhad, et al.
Published: (2004-10-01)

"RELATION OF CHLAMYDIA PNEUMONIAE INFECTION TO DOCUMENTED CORONARY ARTERY DISEASE"
by: M.J. Zibaeenezhad, et al.
Published: (2004-10-01)

Asociación entre enfermedad cardiovascular y anticuerpos contra Chlamydia pneumoniae Association between cardiovascular disease and antibodies against Chlamydia pneumoniae
by: Guadalupe de los A García-Elorriaga, et al.
Published: (2002-06-01)

Interrelationship of interleukin 6, C-reactive protein and Chlamydia pneumoniae IgG antibodies in patients with acute coronary syndromes
by: Burazor Ivana, et al.
Published: (2008-01-01)

CHLAMYDIA PNEUMONIC INFECTION IN CORONARY HEART DISEASE IN BASRAH
by: Hameed. A. Ali, et al.
Published: (2010-06-01)

Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report
by: Ivan M. Petyaev, et al.
Published: (2018-01-01)

Correlation of Chlamydia pneumoniae infection and coronary artery disease in young Indians
by: Satya Nand Pathak
Published: (2014-11-01)

Evaluate the correlation of Inflammatory Cytokines with Chlamydia pneumonia in Coronary Atherosclerotic Patients
by: Ruqaya M. AL-Barzinji, et al.
Published: (2017-10-01)

Chlamydia pneumoniae e doença aterosclerótica = Chlamydia pneumoniae and atherosclerotic disease
by: Sehnem, Luciele, et al.
Published: (2010-01-01)

Seroprevalence of antibodies to chlamydia pneumoniae and legionella pneumophila in mine workers, factory workers and pneumonia patients
by: Bartie, Catheleen
Published: (2016)

<em>Chlamydia pneumoniae</em> infection, inflammation and heat shock protein 60 immunity in asthma and coronary heart disease
by: Sävykoski née Huittinen, T. (Tiina)
Published: (2003)

Antibodies anti-Chlamydia pneumoniae and anti-Mycoplasma pneumoniae in patients with negative serology for hantavirus. Retrospective study
by: M Wilson, et al.
Published: (2001-11-01)

Analysis of intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis patients
by: Gürkov, Robert
Published: (2005)

Lack of association between Chlamydia Pneumoniae serology and endothelial dysfunction of coronary arteries
by: Oehme Albrecht, et al.
Published: (2005-04-01)

Pathohistological changes in diffuse coronary atherosclerosis and chronic infection caused by Chlamydia pneumonia.
by: Mateja Legan, et al.
Published: (2004-02-01)

Prevalência de Chlamydia Pneumoniae e Mycoplasma Pneumoniae em diferentes formas da doença coronariana Prevalencia de Chlamydia Pneumoniae y Mycoplasma Pneumoniae en diferentes formas de la enfermedad coronaria Prevalence of Chlamydia Pneumoniae and Mycoplasma Pneumoniae in different forms of coronary disease
by: Irineu Luiz Maia, et al.
Published: (2009-06-01)

Roquefort Cheese Proteins Inhibit Chlamydia pneumoniae Propagation and LPS-Induced Leukocyte Migration
by: Ivan M. Petyaev, et al.
Published: (2013-01-01)

Chlamydia Pneumoniae Pneumonia: An Evolving Clinical Spectrum
by: David Megran, et al.
Published: (1995-01-01)

Chlamydia pneumoniae and Atherosclerosis: The End?
by: LE Nicolle
Published: (2005-01-01)

Infection biology of Chlamydia pneumoniae
by: Bailey, Leslie
Published: (2008)

Chlamydia pneumoniae and Cardiovascular Disease
by: Lee Ann Campbell, et al.
Published: (1998-12-01)

Chlamydia pneumoniae infection and atherosclerosis
by: Smith, Dr David Andrew
Published: (2004)

Chlamydia pneumoniae Antibodies and C-Reactive Protein Levels in Patients with Abdominal Aortic Aneurysms
by: M. A. Sharif, et al.
Published: (2013-01-01)

Chlamydia pneumoniae immunoglobulin E antibody levels in patients with asthma compared with non-asthma
by: Tamar A. Smith-Norowitz, et al.
Published: (2020-02-01)

Interrelation of individual risk and coronary atherosclerosis in coronary heart disease prognosis
by: E. V. Kotelnikova, et al.
Published: (2004-02-01)

<em>Chlamydia pneumoniae</em> and cardiovascular disease: could we treat cardiovascular disease with antibiotics ?
by: Harmani Kalim
Published: (1998-10-01)

Round pneumonia due to Chlamydia pneumoniae in a child
by: Goro Koinuma, MD, et al.
Published: (2019-04-01)

Analysis of the effect of Chlamydia pneumoniae on the lipid metabolism of mononuclear macrophages in patients with carotid atherosclerotic plaque
by: Qing-Di Zeng, et al.
Published: (2017-06-01)

Hemorheological system in coronary heart disease patients: prognostic value
by: L. I. Malinova, et al.
Published: (2007-06-01)